The Success of Tammy Mazzocco as a Real Estate Agent

Tammy Mazzocco is a member and a keen part of the team at Judy Gang & Associates in Pickerington, Ohio. She is dedicated to the sales of residential real estate in Central Ohio. She takes pride in 2016, as it was the best year in a decade in Ohio’s housing markets. It put up the strongest sales since 2005. In accordance with the Ohio Association of Realtors, there was an increase in home purchases amounting to 7.5 percent over 2015 as the purchases statewide were nearly 151,600 in 2016.

According to the trade group’s president, Pete Kopf, remarkably, the year recorded gains in average prices and sales. Throughout 2016, the year experienced substantial job creation and very low mortgage rates thus creating a favorable environment for house marketing. The upswing is currently threatened by the rising mortgage rates, low supply of available listings, and higher prices. New listings are presently needed in the market, as there are anxious buyers who are actively looking to pounce on the listings that fit their wants. They are currently faced with a challenge, as there are no enough homes available for sale.

Tammy Mazzocco started her successful real estate career as a secretary with a commercial real estate firm called The Edwards Realty Company. Under the leadership of Mike Zelnik, an active commercial Realtor, she worked with a team of nine commercial agents. In 1995, Tammy Mazzocco became a licensed real estate agent. At the time, she had spent seven years at Scotland Yard Condominiums in the condominium management. This was at the suggestion of Ken Cook, a general manager of Scotland Yard and owner of the Cook Realty.

Ken Cook played a vital role in encouraging and teaching Tammy Mazzocco early in her real estate career. Tammy worked for T&R Properties after her exit from Scotland Yard as a multi-site property manager for an office warehouse complex and two apartment complexes. In 1998, Tammy Mazzocco was a licensed personal assistant for Joe Armeni, a RE/MAX producer in the Victoria Village area of Columbus. In 2000, she joined Judy Gang Associates, and she makes sales in residential real estate in Delaware, Franklin, and Fairfield counties in Central Ohio.

For more info, visit Tammys bio.

Contct Tammy Mazzocco via her social media pages:

Trials for New MS Treatment Bring Hope of Remission to Patients

Recent trials involving high-dose immunosuppressive therapy has shown promise in being effective in promoting long-term remission for multiple sclerosis patients. Multiple Sclerosis (MS) attacks the central nervous system and is classified as an autoimmune disease.

After 5 years trials have shown that 69% those patients who have had a transplant of their own blood-forming cells followed by the aforementioned immunosuppressive therapy have shown no advancement in their disability. The trial, known as HALT-MS had the support of the National Institute of Allergy and Infectious Diseases (NIAID) and was conducted by the Immune Tolerance Network (ITN) that they fund.

Those participating in the trial did not take any other medications for MS after the HDIT/HCT (High-Dose Immunosuppressive Therapy and autologous Hematopoietic Cell Transplant), demonstrating that this therapy has a higher success rate than current MS treatments. “Although further evaluation of the benefits and risks of HDIT/HCT is needed” Richard Nash, M.D., of Colorado Blood Cancer Institute and one of the heads of the HALT-MS study, was quoted as saying “These five-year results suggest the promise of this treatment for inducing long-term, sustained remissions of poor-prognosis relapsing-remitting MS.”

There will be larger follow-up studies to confirm the results, and if the same outcomes are observed the treatment will likely be pushed forward to aid those patients that are either unresponsive to current therapies, or who may be thought to benefit from HDIT/HCT.

Dr. Shiva Gopal Vasishta is one of the doctors following this project very closely and specializes in caring for those with complex neurologically based cases, including those involving multiple sclerosis and other auto-immune diseases. Graduating in 1979 Dr. Shiva Gopal Vasishta has 38 years of experience in the industry and continues to stay on top of the most advanced treatments and studies.

Dr. Shiva Gopal Vasishta practices out of Voorhees, New Jersey under license #25MA55133, NPI #1932269982 and can be contacted at (856) 651-0060. His practice is centered in service to the health of his patients, allowing him to accept medicare assignments at the rate offered, meaning no surprise billings for his medicare patients.